Publications in 2016

Hallett M 2016.



Lesurf R, Ragle Aure Miriam,Haberg Mork H, Vitelli V, Kleivi K, Lundgren S, Borresen-Dale A-L, Kristensen VN, Warnberg F, Hallett M, Sorlie T (2016) Molecular features of subtype-specific progression from ductal carcinoma in situ to invasive breast cancer. Cell Reports.16(4): 1166-79.

Boucher B, Lee AY, Hallett M, Jenna S (2016) Structural and functional characterization of a Caenorhabditis elegans genetic interaction network within pathways. PLoS computational biology. 12(2), doi: 10.1371/journal.pcbi.1004738.

Cyr-Depauw C, Northey JJ, Tabariès S, Annis MG, Dong Z, Cory S, Hallett M, Rennhack JP, Andrechek ER, Siegel PM (2016) Chordin-Like 1 suppresses Bone Morphogenetic Protein 4 Induced breast cancer cell migration and invasion. Molecular and cellular biology. 36(10):1509-25.

Boulay PL, Mitchell L, Turpin J, Huot-Marchand JÉ, Lavoie C, Sanguin-Gendreau V, Jones L, Mitra S, Livingstone JM, Campbell S, Hallett M, Mills GB, Park M, Chodosh L, Strathdee D, Norman JC, Muller WJ (2016) Rab11-FIP1C is a critical negative regulator in ErbB2-mediated mammary tumor progression.  Cancer research. 76(9):2662-74.

Turpin J, Ling C, Crosby EJ, Hartman ZC, Simond AM, Chodosh LA, Rennhack JP, Andrechek ER, Ozcelik J, Hallett M, Mills GB, Cardiff RD, Gray JW, Griffith OL, Muller WJ (2016) The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment. Oncogene. 35(47): 6053-64.

Jones LM, Broz ML, Ranger JJ, Ozcelik J, Ahn R, Zuo D, Ursini-Siegel J, Hallett M, Krummel M, Muller MJ (2016) Stat3 establishes an immunosuppressive microenvironment during the early stages of breast carcinogenesis to promote tumor growth and metastasis. Cancer Research 76(6):1416-28.